{"id":2065,"date":"2022-01-24T12:00:56","date_gmt":"2022-01-24T17:00:56","guid":{"rendered":"https:\/\/www.veriheal.com\/blog\/?p=2065"},"modified":"2025-09-25T05:20:19","modified_gmt":"2025-09-25T09:20:19","slug":"cannabinoids-and-the-endocannabinoid-system-a-match-made-in-heaven","status":"publish","type":"post","link":"https:\/\/www.veriheal.com\/blog\/cannabinoids-and-the-endocannabinoid-system-a-match-made-in-heaven\/","title":{"rendered":"Cannabinoids and the Endocannabinoid System: A Match Made in Heaven"},"content":{"rendered":"

Humans were experimenting with cannabis use for medical and recreational purposes before we traveled the Silk Road or even wrote history down (1<\/a>). Archeologists discovered pounds of dried cannabis in ancient Chinese shaman bags, and cannabis was burned as an incense offering at the Holy of Holies altar in a Judahite shrine in Tel Arad, Israel (2<\/a>).<\/p>\n

Yet it wasn\u2019t until we developed advanced biochemistry techniques that we learned why cannabinoids like delta-9-tetrahydrocannabinol (THC)<\/a> have potential medical use for our bodies. The discovery of the cannabinoid receptors CB1 and CB2 in 1988 and 1993, respectively, was just the beginning of our understanding of a complex cell-signaling system called the endocannabinoid system (ECS) (3<\/a>).<\/p>\n

The ECS, also known as the endogenous cannabinoid system, is an extensive feedback network present on virtually all other organ systems that serves as the body\u2019s own \u201cmaster regulator.\u201d This guide will cover the ECS’s parts, the bodily functions it influences, and how it interacts with cannabinoids made by both the body and the cannabis plant.<\/p>\n

    \n
  1. What Is the Endocannabinoid System?<\/a>\n
      \n
    1. The Difference Between Endocannabinoids and Cannabinoids<\/a><\/li>\n
    2. Regulating and Balancing Key Bodily Functions<\/a><\/li>\n<\/ol>\n<\/li>\n
    3. How Does the Endocannabinoid System Work?<\/a>\n
        \n
      1. Endocannabinoids<\/a><\/li>\n
      2. Cannabinoid Receptors<\/a><\/li>\n
      3. Enzymes<\/a><\/li>\n<\/ol>\n<\/li>\n
      4. What Functions Does the Endocannabinoid System Control?<\/a><\/li>\n
      5. What Does THC Do to the Endocannabinoid System?<\/a><\/li>\n
      6. What Does CBD Do to the Endocannabinoid System?<\/a><\/li>\n
      7. What Is Endocannabinoid Deficiency?<\/a><\/li>\n
      8. Final Takeaway<\/a><\/li>\n<\/ol>\n


        \nWhat Is the Endocannabinoid System?<\/b><\/h2>\n

        The body uses the endocannabinoid system to naturally regulate itself using self-made cannabinoids called endocannabinoids (4<\/a>). The ECS is so much more than just the activation of CB1 and CB2 receptors\u2014it\u2019s a way for the body to tell itself that it\u2019s had enough of certain stimuli like pain, brain electrical activity (seizures), pro-inflammatory signals, and more.<\/p>\n

        In addition to CB1 and CB2 receptors, cannabinoids can activate specialized receptors like transient receptor potential (TRP), peroxisome proliferator-activated receptor (PPAR), and G protein-coupled receptor (GPR), as well as target important ECS enzymes like fatty acid amide hydrolase (FAAH), monoacylglycerol (MAG) and diacylglycerol (DAG) lipases, fatty acid-binding proteins (FABP), and cyclooxygenase (COX2) (5<\/a>).<\/p>\n

        Such receptors are the reason why capsaicin reduces pain (TRPV1), glitazone drugs work for diabetes (PPAR), and NSAIDs tone down inflammation in the human body (COX2) (6<\/a>). These are just a few examples of why the ECS is so medically useful.<\/p>\n

        The Difference Between Endocannabinoids and Cannabinoids<\/h3>\n

        Endocannabinoids are the body\u2019s self-made cannabinoids that act as agents of internal control by interacting with cannabinoid receptors. Anandamide (AEA)<\/a> and 2-arachidonoylglycerol (2-AG) are the two best-known endocannabinoids. They are made on-demand from the lipids (fats) in our cells when needed.<\/p>\n

        Interestingly, the endocannabinoids in our bodies do not structurally resemble the cannabinoids found in cannabis plants. Scientifically, these plant-made cannabinoids are called phytocannabinoids (3<\/a>). People commonly refer to these plant-based molecules simply as cannabinoids, which can also act on the ECS.<\/p>\n

        These are cannabinoids like THC, cannabidiol (CBD)<\/a>, cannabigerol (CBG)<\/a>, cannabinol (CBN)<\/a>, cannabidiolic acid (CBDA), tetrahydrocannabinolic acid (THCA)<\/a>, cannabidivarian (CBDV)<\/a>, tetrahydrocannabivarin (THCV)<\/a>, etc. that are in products available for sale in licensed dispensaries.<\/p>\n

        To date, there are almost 150 known cannabinoids (7<\/a>). Cannabis plants also contain a multitude of organic compounds like terpenes<\/a>, which can also influence ECS receptor interactions and cannabis\u2019 effects as well as enhance the potential benefits of cannabinoids through the \u201centourage effect<\/a>\u201d (8<\/a>).<\/p>\n

        Regulating and Balancing Key Bodily Functions<\/h3>\n

        Since the ECS is present on many cells in nearly every organ system, it is involved in a plethora of bodily functions. It is a way for cells, including neurons, to talk to themselves and each other and then agree to regulate activity. As a result, the ECS can regulate various nervous, cardiovascular, digestive, reproductive, immune, and metabolic functions (9<\/a>).<\/p>\n

        The ECS is essential for homeostasis. It influences our sleep, mood, appetite, brain electrical activity, pain perception, nausea and vomiting<\/a>, fear extinction, memory, motor responses, muscle tone, posture, reproduction, and fertility (10<\/a>)(11<\/a>).<\/p>\n

        How Does the Endocannabinoid System Work?<\/h2>\n

        To make a complete feedback loop, some assembly is required. The basic components of the ECS are:<\/p>\n

          \n
        1. Endogenous signaling ligands (self-made endocannabinoids acting as transmitters)<\/li>\n
        2. CB and various other receptors (located on neurons, immune cells, and many others)<\/li>\n
        3. The enzymes that make and break down cannabinoids (FAAH, FABP, MAGL, DAGL, N-acylethanolamine-hydrolyzing acid (NAAA), N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD), and COX)<\/li>\n<\/ol>\n


          \nEndocannabinoids<\/b><\/h3>\n

          Unlike regular neurotransmitters, endocannabinoids are made by special enzymes that trim cell membrane lipids (fats). Endocannabinoids go against the flow of regular signaling (called retrograde transmission). They are all made within the body and are distinct from the cannabinoids found in cannabis plants, though they act on the same receptors.<\/p>\n

          Through the ECS, cells can both give themselves and other cells feedback about the signals they\u2019re sending. The purpose of endocannabinoids is to keep physiologic functions in homeostasis, thus keeping internal processes stable and the body in balance. The two main endocannabinoids are anandamide and 2-arachidonoylglycerol.<\/p>\n

          Anandamide is the molecule responsible for the runner\u2019s high and stress-induced pain relief (12<\/a>). Its levels rise with ovulation, and fluctuations can affect gestational development. Anandamide\u2019s effects on brain reward circuitry are likely implicated in the pleasures of recreational drug consumption and could be a target for treating substance use disorders (13<\/a>).<\/p>\n

          Levels of anandamide are altered in conditions like autism spectrum disorder<\/a>, fibromyalgia<\/a>, complex regional pain disorders, post-traumatic stress disorder (PTSD)<\/a>, psychosis, and schizophrenia (14<\/a>)(15<\/a>). Anandamide is thought to activate TRPV1 receptors, aiding in pain relief and synaptic transmission. Someday, anandamide could be clinically measured to grade the severity of such conditions and patient responses to either conventional or cannabinoid medicine treatment.<\/p>\n

          The endocannabinoid 2-arachidonoylglycerol, or 2-AG, is made through a similar but distinct pathway from anandamide. Interestingly, its levels appear cyclical and coordinate with the time of day, possibly contributing to sleep\/wake cycles and other daily processes. Still, both endocannabinoids are recruited when tissues are injured to suppress pain and inflammatory signals (16<\/a>).<\/p>\n

          2-AG is about 170 times more prevalent in the brain than anandamide (17<\/a>). The brain heavily recruits 2-AG in response to stroke and closed-head injuries to promote neuronal healing, reduce infarct size, and reduce cell death in the hippocampus (memory center) (18<\/a>). It also plays key roles in psychological health and relieving stress-induced pain, like anandamide does (19<\/a>).<\/p>\n

          Similar molecules, like palmitoylethanolamide (PEA), are lipids like endocannabinoids but don\u2019t directly activate CB1 or CB2 receptors (20<\/a>). Instead, they activate PPAR to reduce inflammation<\/a> and tone down the ECS enzymes that break down cannabinoids, which indirectly increases the main endocannabinoids. Though preliminary, PEA is also thought to be potentially useful in managing chronic pain<\/a>.<\/p>\n

          Cannabinoid Receptors<\/h3>\n

          In the brain, the ECS acts as the \u201cmaster synaptic regulator\u201d where CB1 is the most abundant G protein-coupled receptor (GPCR) (6<\/a>)(3<\/a>). Each neuron has hundreds of thousands of synaptic connections that are all actively regulated and self-regulated by the CB1 receptors. This means neurons can give themselves and other neurons feedback by using CB1 receptors to turn down neurotransmitter release and electrical excitability, giving the ECS neuroprotective properties.<\/p>\n

          CB1 plays key roles in regulating neural plasticity, electrical activity, coordination, proprioception, and cognitive function. It is also the receptor responsible for the psychoactive \u201chigh\u201d of cannabis consumption. The highest density of CB1 receptors is in the central nervous system (CNS), but they are also found in GI tract nerves, autonomic nerves, cardiovascular system, endocrine and adipose tissues, and the skin (6<\/a>).<\/p>\n

          CB2 receptors are also present in the brain but to a lesser extent because they exclusively reside in immune cells found in the brain and the rest of the body. In addition to brain immune cells (called microglia), CB2 receptors are also found on various immune cells in the spleen, T cells, macrophages, APCs, and synovial fibroblast cells (6<\/a>).<\/p>\n

          CB2 is a major regulator and modulator of inflammation and immune cells; these receptors can tone down pro-inflammatory markers like cytokines and interleukins. Interestingly, CB2 receptors are also expressed on transformed tumor cells, which could make them a target for future cancer treatment. Both endocannabinoids and cannabinoids<\/a> can partially trigger CB1 and CB2 receptors.<\/p>\n

          Enzymes<\/h3>\n

          The third and often overlooked component of the ECS is the enzymes involved in making and breaking down endocannabinoids. There are many enzymes involved in ECS processes, including NAPE-PLD, FAAH, FABP, monoacylglycerol lipase (MAGL), DAGL, NAAA, and COX2. However, the main ones of therapeutic interest are FAAH and MAGL.<\/p>\n

          FAAH naturally degrades anandamide, while MAGL primarily degrades 2-AG and can also degrade anandamide but more slowly (3<\/a>). By targeting these breakdown enzymes, levels of endocannabinoids will increase and thus improve endocannabinoid tone. We know that plant-based cannabinoids and their acidic forms can also influence the function of these enzymes. For instance, CBD can inhibit FAAH and bind to FABP, thus increasing endocannabinoids.<\/p>\n

          Cannabinoid precursors like CBG, CBGA, CBDA, and THCA can inhibit MAGL and COX-2. COX-2 is the target of NSAIDS and is another enzyme that may be targeted to reduce inflammation. These natural enzyme inhibitors work to increase endocannabinoid tone, and artificial enzyme inhibitors could be developed as non-psychoactive treatments.<\/p>\n

          People can naturally have mutations in ECS enzymes that make them work too fast or too slowly, resulting in different health outcomes and responses to treatments. DAGL creates 2-AG and could theoretically be induced to improve levels of 2-AG. CBDV, CBDVA, and THCVA may weakly inhibit the formation of 2-AG, indirectly antagonizing CB receptor activity (15<\/a>).<\/p>\n

          Thus, ECS enzymes are clinically relevant and call for further study to create new cannabis-based treatments without psychoactive effects. Non-psychoactive treatments like ECS enzyme inducers and inhibitors would be far more tolerable to a wider audience of patients.<\/p>\n

          What Functions Does the Endocannabinoid System Control?<\/h2>\n

          To review, the role of the endocannabinoid system is to act as a master auto-regulator found on virtually every organ system and thus has widespread reach and influence. It allows cells to talk to themselves and give feedback to other cells about the signals being sent to tone them down, supporting homeostasis in the body.<\/p>\n

          Because of the ECS\u2019s prevalence and diversity, it governs all kinds of functions, including the following (21<\/a>)(22<\/a>)(4<\/a>):<\/p>\n